Marcadores moleculares y biomarcadores de imagen: importancia en el avance terapéutico de los tumores cerebrales intraaxiales

Guajardo-Hernández, Ulises; Geisse-Martínez, Federico; Martí-Bonmatí, Luis; Gejman-Enriquez, Roger; Rojas-Zalazar, David.
Int. j. morphol ; 39(2): 601-606, abr. 2021. ilus
Artículo en Español | LILACS | ID: biblio-1385335

Documentos relacionados

  1. Toward digital histopathological assessment in surgery for central nervous system tumors using stimulated Raman histology.
  2. Second window indocyanine green localizes CNS lymphoma in real time in the operating room: report of two cases.
  3. Central Nervous System Tumor With BCL6 Corepressor Internal Tandem Duplication: Treatment Course of a Long-term Survivor.
  4. Unusual presentations of central nervous system myeloid sarcoma.
  5. Fundamentals of Radiation Oncology for Neurologic Imaging.
  6. A phase I study of irinotecan and temozolomide with bevacizumab in children with recurrent/refractory central nervous system tumors.
  7. EMR adoption in Dhaka, Bangladesh: a template to index pediatric central nervous system tumor care and a review of preliminary neuro-oncologic observations.
  8. Blood-brain barrier opening with low intensity pulsed ultrasound for immune modulation and immune therapeutic delivery to CNS tumors.
  9. Neuroimaging to diagnose central nervous system tumours in children.
  10. Newly Recognized CNS Tumors in the 2021 World Health Organization Classification: Imaging Overview with Histopathologic and Genetic Correlation.